Analysts expect Orthofix Medical to report an earnings per share (EPS) of $-0.18.
The announcement from Orthofix Medical is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Performance in Previous Earnings
Last quarter the company beat EPS by $0.28, which was followed by a 1.87% increase in the share price the next day.
Here's a look at Orthofix Medical's past performance and the resulting price change:
Quarter
Q2 2025
Q1 2025
Q4 2024
Q3 2024
EPS Estimate
-0.15
-0.270
-0.05
-0.15
EPS Actual
0.13
-0.081
0.02
0.07
Price Change %
2.00
0.000
-1.00
7.00
Tracking Orthofix Medical's Stock Performance
Shares of Orthofix Medical were trading at $15.44 as of October 31. Over the last 52-week period, shares are down 10.5%. Given that these returns are generally negative, long-term shareholders are likely upset going into this earnings release.
Analysts' Perspectives on Orthofix Medical
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Orthofix Medical.
Analysts have given Orthofix Medical a total of 3 ratings, with the consensus rating being Outperform. ...
